JP2002512206A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002512206A5 JP2002512206A5 JP2000544366A JP2000544366A JP2002512206A5 JP 2002512206 A5 JP2002512206 A5 JP 2002512206A5 JP 2000544366 A JP2000544366 A JP 2000544366A JP 2000544366 A JP2000544366 A JP 2000544366A JP 2002512206 A5 JP2002512206 A5 JP 2002512206A5
- Authority
- JP
- Japan
- Prior art keywords
- combination preparation
- preparation according
- substance
- combination
- gas
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000002360 preparation method Methods 0.000 description 24
- 239000000126 substance Substances 0.000 description 10
- 239000000203 mixture Substances 0.000 description 9
- 239000007789 gas Substances 0.000 description 7
- 150000003904 phospholipids Chemical class 0.000 description 7
- 239000004094 surface-active agent Substances 0.000 description 5
- TXEYQDLBPFQVAA-UHFFFAOYSA-N tetrafluoromethane Chemical compound FC(F)(F)F TXEYQDLBPFQVAA-UHFFFAOYSA-N 0.000 description 4
- 125000002091 cationic group Chemical group 0.000 description 3
- 239000002872 contrast media Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 239000004215 Carbon black (E152) Substances 0.000 description 2
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 description 2
- 108010028921 Lipopeptides Proteins 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine group Chemical group [C@@H]1([C@H](O)[C@H](O)[C@@H](CO)O1)N1C=NC=2C(N)=NC=NC12 OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 125000000129 anionic group Chemical group 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 229960004692 perflenapent Drugs 0.000 description 2
- NJCBUSHGCBERSK-UHFFFAOYSA-N perfluoropentane Chemical compound FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F NJCBUSHGCBERSK-UHFFFAOYSA-N 0.000 description 2
- 125000003367 polycyclic group Chemical group 0.000 description 2
- SFZCNBIFKDRMGX-UHFFFAOYSA-N sulfur hexafluoride Chemical compound FS(F)(F)(F)(F)F SFZCNBIFKDRMGX-UHFFFAOYSA-N 0.000 description 2
- 229960000909 sulfur hexafluoride Drugs 0.000 description 2
- 238000012285 ultrasound imaging Methods 0.000 description 2
- 229940124549 vasodilator Drugs 0.000 description 2
- 239000003071 vasodilator agent Substances 0.000 description 2
- BCNXQFASJTYKDJ-UHFFFAOYSA-N 1,1,2,2,3,3,4,4,5-nonafluoro-5-(trifluoromethyl)cyclopentane Chemical compound FC(F)(F)C1(F)C(F)(F)C(F)(F)C(F)(F)C1(F)F BCNXQFASJTYKDJ-UHFFFAOYSA-N 0.000 description 1
- TXGPGHBYAPBDAG-UHFFFAOYSA-N 1,1,2,2,3,3-hexafluoro-4,4-bis(trifluoromethyl)cyclobutane Chemical compound FC(F)(F)C1(C(F)(F)F)C(F)(F)C(F)(F)C1(F)F TXGPGHBYAPBDAG-UHFFFAOYSA-N 0.000 description 1
- PORPENFLTBBHSG-MGBGTMOVSA-N 1,2-dihexadecanoyl-sn-glycerol-3-phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(O)=O)OC(=O)CCCCCCCCCCCCCCC PORPENFLTBBHSG-MGBGTMOVSA-N 0.000 description 1
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 1
- ABQLAMJAQZFPJI-UHFFFAOYSA-N 3-heptyloxolan-2-one Chemical compound CCCCCCCC1CCOC1=O ABQLAMJAQZFPJI-UHFFFAOYSA-N 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical class C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 1
- 229910018503 SF6 Inorganic materials 0.000 description 1
- ATBOMIWRCZXYSZ-XZBBILGWSA-N [1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexadecanoyloxypropan-2-yl] (9e,12e)-octadeca-9,12-dienoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(COP(O)(=O)OCC(O)CO)OC(=O)CCCCCCC\C=C\C\C=C\CCCCC ATBOMIWRCZXYSZ-XZBBILGWSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 239000003570 air Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- UBAZGMLMVVQSCD-UHFFFAOYSA-N carbon dioxide;molecular oxygen Chemical compound O=O.O=C=O UBAZGMLMVVQSCD-UHFFFAOYSA-N 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- ZGSPNIOCEDOHGS-UHFFFAOYSA-L disodium [3-[2,3-di(octadeca-9,12-dienoyloxy)propoxy-oxidophosphoryl]oxy-2-hydroxypropyl] 2,3-di(octadeca-9,12-dienoyloxy)propyl phosphate Chemical compound [Na+].[Na+].CCCCCC=CCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCC=CCCCCC)COP([O-])(=O)OCC(O)COP([O-])(=O)OCC(OC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC ZGSPNIOCEDOHGS-UHFFFAOYSA-L 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- -1 fatty alcohol ester Chemical class 0.000 description 1
- 150000002391 heterocyclic compounds Chemical class 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- QYSGYZVSCZSLHT-UHFFFAOYSA-N octafluoropropane Chemical compound FC(F)(F)C(F)(F)C(F)(F)F QYSGYZVSCZSLHT-UHFFFAOYSA-N 0.000 description 1
- 229960004624 perflexane Drugs 0.000 description 1
- KAVGMUDTWQVPDF-UHFFFAOYSA-N perflubutane Chemical compound FC(F)(F)C(F)(F)C(F)(F)C(F)(F)F KAVGMUDTWQVPDF-UHFFFAOYSA-N 0.000 description 1
- 229950003332 perflubutane Drugs 0.000 description 1
- ZJIJAJXFLBMLCK-UHFFFAOYSA-N perfluorohexane Chemical compound FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F ZJIJAJXFLBMLCK-UHFFFAOYSA-N 0.000 description 1
- 229960004065 perflutren Drugs 0.000 description 1
- 150000003905 phosphatidylinositols Chemical class 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 150000003335 secondary amines Chemical class 0.000 description 1
- 150000004756 silanes Chemical class 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 239000005526 vasoconstrictor agent Substances 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9808599.6A GB9808599D0 (en) | 1998-04-22 | 1998-04-22 | Improvements in or realting to contrast agents |
| GB9808599.6 | 1998-04-22 | ||
| PCT/GB1999/001221 WO1999053963A1 (en) | 1998-04-22 | 1999-04-22 | Improvements in or relating to contrast agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002512206A JP2002512206A (ja) | 2002-04-23 |
| JP2002512206A5 true JP2002512206A5 (enExample) | 2006-06-15 |
Family
ID=10830802
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000544366A Abandoned JP2002512206A (ja) | 1998-04-22 | 1999-04-22 | 改良された造影剤 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20040146462A1 (enExample) |
| EP (1) | EP1073473B1 (enExample) |
| JP (1) | JP2002512206A (enExample) |
| KR (1) | KR20010042915A (enExample) |
| CN (1) | CN1306442A (enExample) |
| AT (1) | ATE375806T1 (enExample) |
| AU (1) | AU3617299A (enExample) |
| BR (1) | BR9909822A (enExample) |
| CA (1) | CA2329175A1 (enExample) |
| DE (1) | DE69937341D1 (enExample) |
| GB (1) | GB9808599D0 (enExample) |
| HU (1) | HUP0102878A3 (enExample) |
| IL (1) | IL139147A0 (enExample) |
| NO (1) | NO20005250L (enExample) |
| PL (1) | PL343464A1 (enExample) |
| WO (1) | WO1999053963A1 (enExample) |
| ZA (1) | ZA200005789B (enExample) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5804162A (en) * | 1995-06-07 | 1998-09-08 | Alliance Pharmaceutical Corp. | Gas emulsions stabilized with fluorinated ethers having low Ostwald coefficients |
| DE10119522A1 (de) * | 2001-04-20 | 2002-12-05 | Innovacell Biotechnologie Gmbh | Herstellung und Anwendung einer Suspensionszusammensetzung mit einem Ultraschall-Kontrastmittel |
| KR101280760B1 (ko) | 2002-11-29 | 2013-07-05 | 지이 헬스케어 에이에스 | 초음파 조영 물질 |
| US20070128117A1 (en) * | 2003-02-04 | 2007-06-07 | Bracco International B.V. | Ultrasound contrast agents and process for the preparation thereof |
| WO2004069284A2 (en) | 2003-02-04 | 2004-08-19 | Bracco International B.V. | Ultrasound contrast agents and process for the preparation thereof |
| JP5513708B2 (ja) * | 2003-12-22 | 2014-06-04 | ブラッコ・シュイス・ソシエテ・アノニム | 造影イメージング用の気体封入マイクロベシクル・アセンブリー |
| EP1696965B1 (en) * | 2003-12-22 | 2014-12-10 | Bracco Suisse SA | Assembly of gas-filled microvesicle with active component for contrast imaging |
| US9248204B2 (en) | 2004-08-18 | 2016-02-02 | Bracco Suisse S.A. | Gas-filled microvesicles composition for contrast imaging |
| US8153435B1 (en) | 2005-03-30 | 2012-04-10 | Tracer Detection Technology Corp. | Methods and articles for identifying objects using encapsulated perfluorocarbon tracers |
| CN100453050C (zh) * | 2005-09-21 | 2009-01-21 | 北京市肿瘤防治研究所 | 提高超声造影图像分辨力的方法和超声造影成像仪 |
| US20080255266A1 (en) * | 2007-04-10 | 2008-10-16 | Gc Corporation | Dental paste composition having x-ray imaging property |
| JP4279328B2 (ja) * | 2007-05-07 | 2009-06-17 | 株式会社日立製作所 | 超音波撮像システム |
| EP2247314A4 (en) * | 2008-02-01 | 2013-11-27 | Univ Boston | CATIONIC CONTRASTING AGENTS AND METHOD FOR THEIR USE |
| AU2009241762B2 (en) * | 2008-05-02 | 2015-07-16 | Celsense Inc. | Compositions and methods for producing emulsions for nuclear magnetic resonance techniques and other applications |
| US10058837B2 (en) | 2009-08-28 | 2018-08-28 | The Trustees Of Columbia University In The City Of New York | Systems, methods, and devices for production of gas-filled microbubbles |
| DE102011005444A1 (de) * | 2011-03-11 | 2012-09-13 | Innora Gmbh | Festes, negatives Röntgenkontrastmittel zur Darstellung des Gastrointestinaltraktes |
| EP3049117B1 (en) | 2013-09-27 | 2022-07-27 | Exact Therapeutics As | Ultrasound mediated delivery of drugs |
| WO2015091414A2 (de) * | 2013-12-19 | 2015-06-25 | Bayer Pharma Aktiengesellschaft | Substituierte piperidinyl-tetrahydrochinoline |
| CN110913769A (zh) * | 2017-07-09 | 2020-03-24 | 利兰斯坦福初级大学董事会 | 利用频谱合成来减少斑点的超声成像 |
| CA3074629A1 (en) * | 2017-09-07 | 2019-03-14 | Imbiotechnologies Ltd. | Sono-responsive embolic agents |
| CN108586300B (zh) * | 2018-03-28 | 2020-03-17 | 成都福柯斯医药技术有限公司 | 一种s-碘化丁酰硫代胆碱的合成方法 |
| CN114760989A (zh) | 2019-10-25 | 2022-07-15 | 精准医疗股份有限公司 | 胰腺癌的治疗 |
| GB2595513B (en) * | 2020-05-29 | 2023-03-29 | Act Therapeutics Ltd | Treatment of infections |
| US11801058B2 (en) * | 2021-03-04 | 2023-10-31 | Accumedical Beijing Ltd. | Liquid embolic compositions |
| GB2605422B (en) | 2021-03-31 | 2025-04-30 | Act Therapeutics Ltd | Treatment of the central nervous system |
| GB2629999B (en) | 2021-04-21 | 2025-03-26 | Act Therapeutics Ltd | Enhancement of treatment with immunotherapeutic agents |
| CN113598820B (zh) * | 2021-08-18 | 2025-09-23 | 南京超微影医疗科技有限公司 | 超声成像方法及装置 |
| EP4261786A1 (en) * | 2022-03-28 | 2023-10-18 | Tata Consultancy Services Limited | Methods and system for low dose x ray computed tomography perfusion imaging |
| NO20221187A1 (en) | 2022-11-04 | 2024-05-06 | Exact Therapeutics As | Method and system for calculating a point estimate of an ultrasound dose |
| CN116271187B (zh) * | 2023-03-21 | 2025-07-04 | 湖北科技学院 | 双模态显影温敏Pickering乳液介入栓塞材料及其制备方法和应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5580575A (en) * | 1989-12-22 | 1996-12-03 | Imarx Pharmaceutical Corp. | Therapeutic drug delivery systems |
| US5228446A (en) * | 1989-12-22 | 1993-07-20 | Unger Evan C | Gas filled liposomes and their use as ultrasonic contrast agents |
| US5776429A (en) * | 1989-12-22 | 1998-07-07 | Imarx Pharmaceutical Corp. | Method of preparing gas-filled microspheres using a lyophilized lipids |
| US5716597A (en) * | 1993-06-04 | 1998-02-10 | Molecular Biosystems, Inc. | Emulsions as contrast agents and method of use |
| EP0711179B2 (en) * | 1993-07-30 | 2010-09-01 | IMCOR Pharmaceutical Co. | Stabilized microbubble compositions for ultrasound |
| NO940711D0 (no) * | 1994-03-01 | 1994-03-01 | Nycomed Imaging As | Preparation of gas-filled microcapsules and contrasts agents for diagnostic imaging |
| US5846517A (en) * | 1996-09-11 | 1998-12-08 | Imarx Pharmaceutical Corp. | Methods for diagnostic imaging using a renal contrast agent and a vasodilator |
| DE69738406T2 (de) * | 1996-10-21 | 2008-12-04 | Ge Healthcare As | Verbesserungen in oder an Kontrastmitteln |
| WO1998018497A2 (en) * | 1996-10-28 | 1998-05-07 | Nycomed Imaging As | Contrast agents |
| WO1998018498A2 (en) * | 1996-10-28 | 1998-05-07 | Marsden, John, Christopher | Improvements in or relating to diagnostic/therapeutic agents |
| EP0991427A2 (en) * | 1996-10-28 | 2000-04-12 | Marsden, John Christopher | Improvements in or relating to diagnostic/therapeutic agents |
-
1998
- 1998-04-22 GB GBGB9808599.6A patent/GB9808599D0/en not_active Ceased
-
1999
- 1999-04-22 AU AU36172/99A patent/AU3617299A/en not_active Abandoned
- 1999-04-22 JP JP2000544366A patent/JP2002512206A/ja not_active Abandoned
- 1999-04-22 IL IL13914799A patent/IL139147A0/xx unknown
- 1999-04-22 WO PCT/GB1999/001221 patent/WO1999053963A1/en not_active Ceased
- 1999-04-22 CN CN99807622A patent/CN1306442A/zh active Pending
- 1999-04-22 PL PL99343464A patent/PL343464A1/xx unknown
- 1999-04-22 DE DE69937341T patent/DE69937341D1/de not_active Expired - Lifetime
- 1999-04-22 HU HU0102878A patent/HUP0102878A3/hu unknown
- 1999-04-22 BR BR9909822-9A patent/BR9909822A/pt not_active IP Right Cessation
- 1999-04-22 AT AT99918133T patent/ATE375806T1/de not_active IP Right Cessation
- 1999-04-22 EP EP99918133A patent/EP1073473B1/en not_active Expired - Lifetime
- 1999-04-22 KR KR1020007011727A patent/KR20010042915A/ko not_active Withdrawn
- 1999-04-22 CA CA002329175A patent/CA2329175A1/en not_active Abandoned
-
2000
- 2000-10-18 ZA ZA200005789A patent/ZA200005789B/xx unknown
- 2000-10-19 NO NO20005250A patent/NO20005250L/no not_active Application Discontinuation
-
2003
- 2003-11-19 US US10/717,196 patent/US20040146462A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2335206T3 (es) | Liposomas llenos de gas que comprenden un gas insoluble en combinacion con un gas soluble. | |
| RU99110367A (ru) | Улучшенные контрастные агенты или усовершенствования, относящиеся к ним | |
| DE69720979T2 (de) | Thermostabilisiertes kontrastmittel | |
| AU721923B2 (en) | Novel compositions of lipids and stabilizing materials | |
| Kabalnov et al. | Phospholipids as emulsion stabilizers: 2. Phase behavior versus emulsion stability | |
| US5658551A (en) | Stable microbubbles suspensions injectable into living organisms | |
| CA2246779C (en) | Improvements in or relating to contrast agents | |
| US6146657A (en) | Gas-filled lipid spheres for use in diagnostic and therapeutic applications | |
| US9364569B2 (en) | Ultrasound contrast agents and process for the preparation thereof | |
| US6551576B1 (en) | Container with multi-phase composition for use in diagnostic and therapeutic applications | |
| Szijjarto et al. | Effects of perfluorocarbon gases on the size and stability characteristics of phospholipid-coated microbubbles: Osmotic effect versus interfacial film stabilization | |
| Miñones Jr et al. | Interactions between membrane sterols and phospholipids in model mammalian and fungi cellular membranes—A Langmuir monolayer study | |
| HK1006945A1 (en) | Improvements in or relating to contrast agents | |
| KR960700757A (ko) | 초음파 콘트라스트 매질로서 유용한 가스 혼합물(gas mixtures useful as ultrasound contrast media) | |
| JPH11507873A (ja) | 最適サイズのガス−充填小胞を作成するための装置および方法 | |
| Nakamura et al. | Two-component Langmuir monolayers of single-chain partially fluorinated amphiphiles with dipalmitoylphosphatidylcholine (DPPC) | |
| JP2004524368A5 (enExample) | ||
| JP2002512206A (ja) | 改良された造影剤 | |
| Frangopol et al. | Interactions of some local anesthetics and alcohols with membranes | |
| Nguyen et al. | A nonpolar, nonamphiphilic molecule can accelerate adsorption of phospholipids and lower their surface tension at the air/water interface | |
| JP2021519324A5 (enExample) | ||
| Hiranita et al. | Miscibility behavior of dipalmitoylphosphatidylcholine with a single-chain partially fluorinated amphiphile in Langmuir monolayers | |
| Li et al. | Multilayer formation on a curved drop surface | |
| Shibata et al. | Mixed Langmuir monolayers made from single-chain perfluoroalkylated amphiphiles | |
| ES2243350T3 (es) | Agente de contraste liofizable que comprende microburbujas de gas. |